-+ 0.00%
-+ 0.00%
-+ 0.00%

Chardan Capital Maintains Buy on Senti Biosciences, Raises Price Target to $12

Benzinga·12/04/2024 12:21:21
Listen to the news
Chardan Capital analyst Geulah Livshits maintains Senti Biosciences (NASDAQ:SNTI) with a Buy and raises the price target from $10 to $12.